CompanyGraph
Fortive Corporation
FTV · NYSE Arca · United States
Builds NIST-traceable electrical test instruments and FDA-cleared hydrogen peroxide plasma sterilization systems whose calibration and consumable dependencies make each product non-substitutable at the point of regulatory compliance.
Fortive's two product lines — Fluke electrical test instruments and Sterrad sterilization systems — each generate mandatory return events not by customer choice but because regulatory validity expires: OSHA-mandated accuracy thresholds require NIST-traceable recalibration of Fluke instruments before and after field deployment, and FDA 510(k) clearance binds the Sterrad hydrogen peroxide formulation to its plasma chamber as a single validated unit, requiring continuous proprietary consumable replenishment. Switching costs compound this lock-in, because replacing either product line forces customers through full revalidation of their regulated procedures, making substitution operationally equivalent to a compliance restart. The recalibration dependency that anchors Fluke customers also defines the binding constraint on geographic expansion, since each new market requires an ISO 17025 accredited metrology laboratory staffed with certified technicians before legal recalibration can occur — infrastructure that cannot be virtualized, so service reach grows only as fast as those laboratories can be built and staffed. The same regulatory co-validation that prevents Sterrad customers from switching also concentrates supply risk, because any disruption to the proprietary concentrate has no compliant substitution path and halts sterilization cycles across every dependent hospital until supply resumes or a full FDA revalidation of an alternative formulation clears.
How does this company make money?
Income enters through three mechanics: per-unit sales of Fluke electrical instruments and Sterrad sterilization systems; recurring sales of Sterrad hydrogen peroxide consumable cartridges charged on a per-cycle basis; and calibration service contracts for Fluke instruments billed annually or per service event.
What makes this company hard to replace?
Sterrad sterilization systems require FDA validation of the entire sterilization cycle — including the specific hydrogen peroxide formulations — so any hospital switching to an alternative system must complete a full revalidation of its sterile processing protocols before the substitute can be used. Fluke instruments become embedded in customer calibration procedures such that changing to a different vendor requires requalifying measurement methods with the relevant regulatory bodies.
What limits this company?
Each new geographic market for Fluke servicing requires a temperature-controlled, ISO 17025 accredited metrology laboratory staffed with certified technicians capable of maintaining NIST-traceable reference standards. Because that infrastructure cannot be virtualized or outsourced to uncertified facilities, the number of locations where field instruments can be legally recalibrated grows only as fast as certified laboratories can be established and staffed.
What does this company depend on?
The two product lines depend on five named upstream inputs: NIST-traceable reference standards for electrical measurement calibration; FDA 510(k) clearances for Sterrad sterilization systems; hydrogen peroxide concentrate supply for Sterrad consumables; ISO 17025 accredited calibration laboratories; and semiconductor components for Fluke electrical measurement circuits.
Who depends on this company?
Hospital sterile processing departments depend on Sterrad sterilization cycles to maintain operating room turnover capacity, and a loss of those cycles directly reduces the rate at which surgical instruments can be cleared for reuse. Electrical technicians in manufacturing facilities depend on Fluke voltage measurement accuracy to satisfy safety compliance requirements under OSHA. Pharmaceutical facilities depend on calibrated Fluke instruments for the batch release documentation that underpins their process validation records.
How does this company scale?
Software features and measurement algorithms replicate across Fluke instrument production at near-zero marginal cost. The bottleneck that resists scaling is the requirement for NIST-traceable calibration infrastructure at service locations, where each new geographic market requires ISO 17025 accredited metrology laboratories staffed with trained technicians before legal recalibration can occur.
What external forces can significantly affect this company?
FDA medical device regulations requiring sterile processing validation in hospitals drive Sterrad demand cycles. OSHA electrical safety standards mandate calibrated test equipment in industrial facilities, sustaining the recalibration requirement for Fluke instruments. Export control restrictions on advanced measurement technology limit international expansion in certain jurisdictions.
Where is this company structurally vulnerable?
Because the FDA clearance binds the hydrogen peroxide formulation to the plasma chamber as a single validated unit, any disruption to the proprietary concentrate supply has no compliant substitution path. A supply failure does not merely interrupt consumable delivery — it halts every Sterrad sterilization cycle in every hospital running the system until either supply resumes or a full revalidation of an alternative formulation clears the FDA, during which time hospital operating room turnover capacity dependent on those cycles is lost.